Clarivate- Life Sciences & Healthcare Business

What Clarivate- Life Sciences & Healthcare Business does

Clarivate's Life Sciences & Healthcare business is the life sciences segment of Clarivate PLC, a publicly traded company (NYSE: CLVT) that operates across three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The Life Sciences & Healthcare business delivers AI-powered intelligence platforms, enriched data, predictive analytics, and expert-driven consulting to pharmaceutical, biotechnology, medtech, and diagnostic companies across the full drug lifecycle — from discovery and pre-clinical research through clinical trials, regulatory submission, commercialization, and post-market safety surveillance.

The core product architecture is a platform-plus-modules model anchored by Cortellis, which provides unified access to drug pipeline data, competitive intelligence, deals analytics, regulatory intelligence, clinical trials intelligence, and product performance data. Specialized add-ons include DRG Market Assessment and Epidemiology Intelligence for market sizing and patient forecasting, OFF-X and Drug Safety Triager for AI-driven pharmacovigilance and safety signal detection, BioWorld for biotech news, Medtech 360 for medical device markets, MetaCore and Key Pathway Advisor for pathway analysis, and Market Access Intelligence plus Healthcare Business Insights (HBI) for commercialization. The portfolio is complemented by expert consulting services and a documented API suite (Cortellis CMC, Drug Discovery, Deals, Clinical Trials, Epidemiology, Market Access, Derwent Patent Data, Darts-ip, Web of Science APIs) enabling integration into customer systems. More than 700 deep subject-matter experts across 40+ countries curate data and deliver consulting work.

The business monetizes primarily through enterprise subscription contracts (annual and multi-year, seat-based and enterprise agreements) for access to intelligence platforms, supplemented by professional services revenue from expert consulting engagements. Go-to-market is sales-led with direct enterprise sales teams, account management, and 24/7 localized customer support across Americas, EMEA, and APAC. Pricing is quote-based and not publicly disclosed. Customers include named enterprise logos such as Asahi Kasei, Cleo Diagnostics, and Gedeon Richter, and the platform is trusted by millions of users globally across academia, life sciences, and IP workflows.

Name

Clarivate- Life Sciences & Healthcare Business

Legal name

Clarivate Analytics (UK) Limited

Website

https://clarivate.com

Company type

Public

Operating status

Operating

Short description

Clarivate's Life Sciences & Healthcare business delivers AI-powered intelligence platforms, enriched data, predictive analytics, and expert consulting to pharmaceutical, biotechnology, medtech, and diagnostics companies across the drug lifecycle. It operates the Cortellis platform alongside DRG, BioWorld, Medtech 360, OFF-X, and Knowledge Graphs.

Ownership category

akta.pro rank

Product category

Life Sciences Intelligence Platforms

NAICS

Software Publishers (5132), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), Pharmacovigilance & Drug Safety Software (HLAGAJAK), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

Keywords

• Life sciences intelligence
• Drug pipeline analytics
• Clinical trial intelligence
• Healthcare market access
• Pharmacovigilance solutions

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices15 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Subscription-based data and analytics: Annual and multi-year subscription contracts for access to intelligence platforms including Cortellis, DRG, and Medtech solutions. Revenue driven by seat-based licensing and enterprise agreements.
2. Professional consulting services: Expert consulting services utilizing integrated research, data, and analytics for commercial and R&D decision-making. Highly experienced team of expert consultants across therapeutic areas.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Clarivate's Life Sciences & Healthcare business sells AI-powered intelligence platforms, curated data, and expert consulting services that support pharmaceutical, biotech, and medtech companies across the drug lifecycle—from discovery, clinical trials, regulatory compliance, and pharmacovigilance through market access and commercialization. Core offerings are anchored by the Cortellis platform and complemented by specialized solutions such as DRG epidemiology, OFF-X safety intelligence, BioWorld news, Medtech 360, MetaCore pathway analysis, and expert consulting.

Product overview

Clarivate's Life Sciences & Healthcare business offers a comprehensive portfolio of AI-powered intelligence solutions organized around the Cortellis platform as the central hub. Cortellis provides unified access to drug pipeline data, competitive intelligence, deals analytics, regulatory intelligence, clinical trials intelligence, and product performance data across the pharmaceutical R&D and commercial lifecycle. Supporting the Cortellis platform are specialized solutions including DRG Market Assessment and Epidemiology Intelligence for market forecasting, OFF-X and Drug Safety Triager for pharmacovigilance, BioWorld for biotech news intelligence, Medtech 360 for medical device markets, and MetaCore/Key Pathway Advisor for pathway analysis. The company also provides expert consulting services and APIs for system integration. Additionally, Clarivate offers an extensive Intellectual Property portfolio including IPfolio for IP management, Derwent Patent Search and Analytics for patent intelligence, CompuMark for trademark solutions, and Darts-ip for litigation intelligence, as well as Web of Science for academic research. The overall architecture is a platform-plus-modules model where Cortellis serves as the central intelligence hub with specialized add-on products and services addressing specific workflow needs across drug discovery, development, commercialization, and IP management.

Differentiator

Problem solved

Functional benefit

Brands

• Web of Science: Premier scholarly and scientific research platform for research discovery and referencing
• Cortellis
• Derwent
• IPfolio
• ProQuest
• Ex Libris
• CompuMark
• Darts-ip
• BioWorld
• Medtech 360

Products and services

• Cortellis Central AI-powered intelligence platform for Life Sciences & Healthcare providing drug pipeline data, competitive intelligence, deals analytics, regulatory intelligence, and clinical trial intelligence across the pharmaceutical R&D lifecycle. Used by pharmaceutical and biotech companies for portfolio strategy and decision-making.
• DRG Market Assessment Market assessment and forecasting solution providing disease-specific market sizing, patient populations, and treatment trend analysis for pharmaceutical and biotech companies.
• DRG Epidemiology Intelligence Epidemiological data and analytics providing disease prevalence, incidence, and patient population projections across global markets for life sciences companies.
• DRG Fusion Commercial execution analytics platform integrating commercial data, prescriber insights, and sales performance metrics for life sciences companies.
• OFF-X Translational safety intelligence platform using AI to predict and assess safety signals and off-target effects in drug discovery and development. Used by pharmacovigilance and safety teams in pharmaceutical companies.
• Drug Safety Triager AI-powered drug safety triage and assessment tool for pharmacovigilance workflows and adverse event processing.
• Dialog Pharmacovigilance and drug safety intelligence platform providing access to safety databases, literature monitoring, and signal detection tools.
• BioWorld Biotech and pharma news service providing AI-analyzed coverage of industry developments, deals, and scientific advances for life sciences professionals.
• Medtech 360 Medtech market intelligence platform providing data on medical device markets, procedures, and competitive landscape for strategic decision-making by medical device and diagnostic companies.
• Market Access Intelligence Market access analytics providing reimbursement data, pricing intelligence, and health technology assessment information for market entry strategies.
• Healthcare Business Insights (HBI) Healthcare commercial insights platform providing data on market dynamics, competitive positioning, and business performance metrics for healthcare organizations.
• MetaCore Pathway analysis and systems biology platform providing gene-disease-drug relationship data for mechanism of action research in drug discovery.
• Key Pathway Advisor Pathway analysis tool helping researchers understand biological pathways and mechanisms relevant to drug discovery.
• Consulting Services Expert consulting services across commercial strategy, R&D, technology, and integrated patient journey for life sciences companies, delivered by Clarivate's team of experienced consultants across therapeutic areas.

Quantifiable outcome

• Trusted by millions globally for transformative intelligence

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Elsevier (RELX Group): Elsevier, part of RELX, is a global scientific information and analytics provider with Scopus, Embase, Reaxys, and ClinicalPathway offerings that compete with Clarivate's literature monitoring, drug discovery intelligence, and pathway analysis products.
• Springer Nature: Springer Nature operates a major scientific publishing portfolio (Nature, Springer, BMC) and adjacent data products (e.g., AdisInsight for drug pipeline intelligence) that overlap with Web of Science and Cortellis competitive intelligence.
• Wolters Kluwer: Wolters Kluwer provides pharma compliance, clinical decision support, and healthcare regulatory information (e.g., Medi-Span, Sentri7) that overlap with Cortellis Regulatory Intelligence and pharmacovigilance modules.
• Oracle Health Sciences: Oracle Health Sciences provides clinical trial and safety platforms (Clinical One, Argus, InForm) that compete with Cortellis Clinical Trials Intelligence and pharmacovigilance modules, plus broader pharma software stack integration.

Direct peers

• Veeva Systems: Veeva provides cloud software for pharma and life sciences including Veeva Vault for regulatory, clinical, and quality workflows, directly competing with Cortellis Regulatory Intelligence and broader pharma R&D data platforms.
• Definitive Healthcare: Definitive Healthcare provides healthcare commercial intelligence, including hospital and physician data, market access, and provider analytics, competing with DRG Market Assessment and Healthcare Business Insights offerings.
• Evidera (PPD / Thermo Fisher): Evidera, part of PPD/Thermo Fisher, delivers real-world evidence, epidemiology, and market access consulting and analytics, directly overlapping with DRG Epidemiology Intelligence and Market Access Intelligence offerings.
• IQVIA: IQVIA is the largest global provider of clinical trial services, real-world evidence, and life sciences commercial intelligence, with R&D Solutions and Technology & Analytics segments that directly overlap with Clarivate's clinical trials intelligence, epidemiology, and market access offerings.
• Informa Pharma Intelligence: Informa Pharma Intelligence (formerly Pharma Intelligence, Datamonitor Healthcare, Sitetrove, TrialTrove) provides pharma pipeline, clinical trial, deals, and epidemiology intelligence that closely mirrors Clarivate's Cortellis portfolio and BioWorld news service.

Emerging players

• Palantir Technologies: Palantir's Foundry platform is increasingly deployed by pharma (e.g., FDA, NHS, AstraZeneca) for life sciences data integration and AI workflows, positioning it as a potential disruptive alternative to traditional intelligence platforms like Cortellis.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/clarivate
• YouTubeyoutube.com/clarivate
• Facebookfacebook.com/clarivate
• LinkedInlinkedin.com/company/clarivate-analytics
• Instagraminstagram.com/lifeatclarivate

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clarivate- Life Sciences & Healthcare Business